News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Baxter BioScience Corporation (BAX) Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital


1/5/2012 6:06:09 AM

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX) has been notified of an unsolicited “mini-tender” offer by TRC Capital Corporation to purchase up to 2 million shares, or approximately 0.35 percent, of Baxter’s outstanding common stock at a price of $46.10 per share in cash. The offer price was 4.67 percent below the $48.36 closing price of Baxter’s common stock on December 15, 2011, the day prior to the offer. TRC’s offer is subject to a number of conditions, including TRC’s ability to obtain financing necessary to consummate the offer.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES